Results 151 to 160 of about 6,225,689 (197)

Immune-related biomarkers in liquid biopsy for cancer: emerging tools for non-invasive precision oncology. [PDF]

Front Cell Dev Biol
Wen L, Wang X, Liu J, Pan X, Zhang Y, Li S, Tong M, Jiang Y, Guan H.   +8 more
europepmc   +1 more source

Slug-positive circulating tumor cells in mesenchymal malignancies: what remains to validate. [PDF]

J Cancer Res Clin Oncol
Gholami AA, Mirzaeva D, Soleyeva S.
europepmc   +1 more source

Combining Napsin A expression with circulating tumor cell counts for enhanced identification of pulmonary adenocarcinoma in ground-glass nodules. [PDF]

Transl Cancer Res
Ruan S, Yu H, Song Z, Zhu X, Yuan G, Xie H, Zhang C, Wei T.   +7 more
europepmc   +1 more source

Immune escape in portal vein tumor thrombus: an intravascular tumor-immune niche framework for hepatocellular carcinoma. [PDF]

Front Immunol
Li X, Ma D, Yuan Z, Zhu J, Gao J.
europepmc   +1 more source

USF2-Mediated APOE-Cholesterol Signaling Promotes CTC Clustering and Metastasis in Non-Small Cell Lung Cancer. [PDF]

Int J Mol Sci
Li Z, Cui M, Sun L, Qin H, Shen X, Gao W.   +5 more
europepmc   +1 more source

Multi-Omics and Liquid Biopsy Integration for Precision Stratification of Breast Cancer. [PDF]

Cancers (Basel)
Sharma D, Srivastava S, Sridhar SB, Shareef J, Sahu R, Budha RR, Tariq M, Kamal MA.   +7 more
europepmc   +1 more source

Liquid biopsies for detection, characterization, and interception of therapy resistance in thoracic malignancies. [PDF]

Front Oncol
Oner E, M Saini V, Cahill C, O'Toole H, Li JW, Gately K, Anagnostou V.   +6 more
europepmc   +1 more source

CellSearch-based isolation of circulating tumor cells from ascitic fluid enables molecular characterization of ovarian cancer. [PDF]

J Liq Biopsy
Gorini F, Maloberti T, Coschina E, Mezzapesa F, Petrovic B, Gallerani G, Ferracin M, Scarpelli E, De Leo A, Kurelac I, De Iaco P, Angelini S, Perrone AM, de Biase D, Ravegnini G.   +14 more
europepmc   +1 more source